Clinical Trial Update: VIZ ACCESS HCM - Multi-Site Registry

View source ↗

Summary

A multi-site registry study called VIZ ACCESS HCM sponsored by Viz.ai, Inc. is currently recruiting participants with Hypertrophic Cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Snippet

Sponsor: Viz.ai, Inc. | Conditions: Hypertrophic Cardiomyopathy | Status: RECRUITING